Previous smallpox vaccine provides immunity to Mpox
Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from
Stay updated with breaking news from Cell Host. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from
Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from Karolinska Institutet in Sweden report in a study published in the scientific journal Cell Host & Microbe.
A scientific review concluded that fecal microbiota transplantation is more effective than antibiotics against recurrent ‘Clostridioides difficile’ infections; researchers are also investigating its possibilities in mental health and to improve the effect of immunotherapy in cancer
SM1B74 was more effective than existing antibiotics and worked in synergy with vancomycin to increase pathogen clearance in an animal model of bacteremia.
A new bioengineered drug candidate demonstrated superior performance to a standard antibiotic at treating mice infected with Staphylococcus aureus, according to results from early testing published April 24 in Cell Host & Microbe.